Strauss‐Albee et al., 2017 - Google Patents

The newborn human NK cell repertoire is phenotypically formed but functionally reduced

Strauss‐Albee et al., 2017

View PDF @Full View
Document ID
15646789450342669878
Author
Strauss‐Albee D
Liang E
Ranganath T
Aziz N
Blish C
Publication year
Publication venue
Cytometry Part B: Clinical Cytometry

External Links

Snippet

Background Infection is a leading cause of death worldwide in babies under 1 month of age. Better vaccines and therapeutics are desperately needed for this vulnerable population. Methods Because newborns rely heavily on the innate immune system, we evaluated cell …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Similar Documents

Publication Publication Date Title
Strauss‐Albee et al. The newborn human NK cell repertoire is phenotypically formed but functionally reduced
Nielsen et al. Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages in vitro
Anfossi et al. Human NK cell education by inhibitory receptors for MHC class I
Gherardin et al. Human blood MAIT cell subsets defined using MR1 tetramers
Alculumbre et al. Diversification of human plasmacytoid predendritic cells in response to a single stimulus
Scapini et al. Human neutrophils in the saga of cellular heterogeneity: insights and open questions
Yu et al. CD4+ CD25+ CD127 low/− T cells: a more specific Treg population in human peripheral blood
Yun et al. Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells
Fuhrman et al. Divergent phenotypes of human regulatory T cells expressing the receptors TIGIT and CD226
Lopez-Vergès et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
Cameron et al. Differential surface phenotype and context‐dependent reactivity of functionally diverse NKT cells
Longhi et al. Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease
Ma et al. Flow cytometric-based analysis of defects in lymphocyte differentiation and function due to inborn errors of immunity
AU2015222944A1 (en) T cell balance gene expression, compositions of matters and methods of use thereof
KR20110134386A (en) Compositions and methods for assessing cytotoxicity of single cells
Garcia Santana et al. Human treg cells are characterized by low/negative CD6 expression
Kovalenko et al. Identification of human memory‐like NK cells
Matos et al. Maturation and phenotypic heterogeneity of human CD4+ regulatory T cells from birth to adulthood and after allogeneic stem cell transplantation
Pickering et al. NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant
Makwana et al. Asymptomatic CMV infections in long‐term renal transplant recipients are associated with the loss of FcRγ from LIR‐1+ NK cells
Pieren et al. Co-expression of TIGIT and Helios marks immunosenescent CD8+ T cells during aging
Nguyen et al. Increased cytotoxicity of CD4+ invariant NKT cells against CD4+ CD25hiCD127lo/–regulatory T cells in allergic asthma
Holder et al. Natural killer cells adapt to cytomegalovirus along a functionally static phenotypic spectrum in human immunodeficiency virus infection
Brown et al. Human CD4+ CD25+ CD226-tregs demonstrate increased purity, lineage stability, and suppressive capacity versus CD4+ CD25+ CD127lo/-tregs for adoptive cell therapy
Ariga et al. Instruction of naive CD4+ T‐cell fate to T‐bet expression and T helper 1 development: roles of T‐cell receptor‐mediated signals